- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07935460
Infection Rate With Intramedullary Interlocking Nail Versus Plate Fixation in Open Tibial Fractures
Infection Rate of ILN vs Plate in Open Fracture Tibia Treated With Prophylactic Antibiotic
Open fractures of the tibia are at risk of infection because the injury damages the surrounding soft tissues. This study will compare the frequency of postoperative infection in patients with Gustilo-Anderson type I and II open tibial shaft fractures treated with intramedullary interlocking nail (ILN) fixation or plate fixation after three days of intravenous prophylactic antibiotic therapy.
A total of 170 patients aged 18-60 years will be included and randomly allocated into two groups of 85 patients each. Group A will undergo ILN fixation, while Group B will undergo plate fixation. Patients will be monitored for signs of infection, including pain, redness, swelling, and wound discharge, during hospital stay and follow-up. The main outcome will be the presence of postoperative infection within three months of surgery.
The findings may help clinicians compare infection rates between these two fixation methods in open tibial shaft fractures.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Muhammad Asif Asif Khan, post graduate trainee orthopa
- Telefonnummer: +923012996395
- E-mail: wazirkhancr768@gmail.com
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Inclusion Criteria
- Patients aged 18-60 years.
- Both genders.
- Gustilo-Anderson type I and II open tibial shaft fractures.
- Patients receiving three days of intravenous antibiotic therapy prior to definitive fixation.
Exclusion Criteria:
-
• Gustilo-Anderson type III fractures.
- Pathological fractures.
- Polytrauma patients.
- Patients with diabetes mellitus, immunosuppression, or peripheral vascular disease.
- Previous surgery on the affected limb
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Arm 1Intramedullary Interlocking Nail Fixation
Patients will undergo surgical fixation of open tibial fractures using an intramedullary interlocking nail. |
Surgical fixation of open tibial fractures using an intramedullary interlocking nail. |
|
Aktiv komparator: Arm 2 Plate Fixation
Patients will undergo surgical fixation of open tibial fractures using plate fixation. |
Surgical fixation of open tibial fractures using plate and screw fixation. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Frequency of Postoperative Infection
Tidsramme: Within 3 months after surgery
|
Postoperative infection will be assessed by the presence of clinical signs of infection, including pain, redness, swelling, and wound discharge, with or without a positive wound culture. Infection rates will be compared between patients treated with intramedullary interlocking nail fixation and plate fixation. |
Within 3 months after surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Postoperative Pain Score
Tidsramme: Third postoperative day
|
Postoperative pain will be assessed using the Visual Analog Scale (VAS) and compared between the two treatment groups. |
Third postoperative day
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 48.ERC/FMU/2025-26/366
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Individual participant data will not be shared with other researchers. The data will be kept confidential and used only for the purposes of this research study. Access to study data will be restricted to authorized members of the research team.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .